Vimarsana
Biggest News Aggregation in the World

Page 5 - Ichnos Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ichnos Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ichnos Sciences Today - Breaking & Trending Today

ICHNOS SCIENCES DATA SELECTED FOR PRESENTATION AT THE 64TH ASH ANNUAL MEETING - Vimarsana News

ICHNOS SCIENCES DATA SELECTED FOR PRESENTATION AT THE 64TH ASH ANNUAL MEETING

/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...

ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442 - Vimarsana News

ICHNOS SCIENCES ANNOUNCES INITIATION OF FIRST-IN-HUMAN STUDY FOR ISB 1442

/PRNewswire/ -- Ichnos Sciences Inc., a global clinical-stage biotechnology company developing innovative multispecific immune cell engager antibodies in...

Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases - Vimarsana News

Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases

Almirall announces the initiation of a Phase I study of anti-IL-1RAP first-in-class monoclonal antibody for autoimmune dermatological diseases The Phase I study will evaluate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of ALM27134* ALM27134 has the potential to treat underserved patien...

Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for Q1 FY 2022-23 - Vimarsana News

Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for Q1 FY 2022-23

Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd

ICHNOS SCIENCES TO PRESENT AT THE 2022 JEFFERIES HEALTHCARE CONFERENCE - Vimarsana News

ICHNOS SCIENCES TO PRESENT AT THE 2022 JEFFERIES HEALTHCARE CONFERENCE

/PRNewswire/ -- Ichnos Sciences Inc., a clinical-stage global biotechnology company developing innovative multispecific antibodies for oncology, today...